Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Resistance patterns with tyrosine kinase inhibitors in melanoma: new insights.

Resistance patterns with tyrosine kinase inhibitors in melanoma: new insights. Curr Opin Oncol. 2012 Mar; 24(2):150-4.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.